FDA.reportPublic FDA data

2 ML golodirsen 50 MG/ML Injection

RxCUI
2267211
RxNorm name
2 ML golodirsen 50 MG/ML Injection
Display name
2 ML golodirsen 50 MG/ML Injection
Full name
2 ML golodirsen 50 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Vyondys 53GOLODIRSENSarepta Therapeutics, Inc.35c227d1-5b24-44b0-b5d3-f0f6b1c46bd52025-03-13Warnings, Adverse reactionsExact identifier
rxcui: 2267211

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
35c227d1-5b24-44b0-b5d3-f0f6b1c46bd5golodirsen 100 MG in 2 ML Injection [PSN] · 2 ML golodirsen 50 MG/ML Injection [SCD] · golodirsen 100 MG per 2 ML Injection [SY]316These highlights do not include all the information needed to use VYONDYS 53 safely and effectively. See full prescribing information for VYONDYS 53. VYONDYS 53 (golodirsen) injection, for intravenous use Initial U.S. Approval: 201920250313